FSSNX
Price
$26.25
Change
-$0.48 (-1.80%)
Updated
Jun 13 closing price
Net Assets
24.88B
JDSCX
Price
$31.05
Change
-$0.59 (-1.86%)
Updated
Jun 13 closing price
Net Assets
1.46B
Interact to see
Advertisement

FSSNX vs JDSCX

Header iconFSSNX vs JDSCX Comparison
Open Charts FSSNX vs JDSCXBanner chart's image
Fidelity Small Cap Index
Price$26.25
Change-$0.48 (-1.80%)
VolumeN/A
Net Assets24.88B
JPMorgan Small Cap Blend I
Price$31.05
Change-$0.59 (-1.86%)
VolumeN/A
Net Assets1.46B
FSSNX vs JDSCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. JDSCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Hold and JDSCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 24.9B vs. JDSCX (1.47B). FSSNX pays higher dividends than JDSCX: FSSNX (1.10) vs JDSCX (0.95). FSSNX was incepted earlier than JDSCX: FSSNX (14 years) vs JDSCX (26 years). JDSCX (1.02) is less costly to investors than FSSNX (0.03). JDSCX is a more actively managed with annual turnover of: 39.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than JDSCX: FSSNX (0) vs JDSCX (1000000). FSSNX annual gain was more profitable for investors over the last year : 4.63 vs. JDSCX (2.73). FSSNX return over 5 years is better than : 58.19 vs. JDSCX (43.91).
FSSNXJDSCXFSSNX / JDSCX
Total Expense Ratio0.030.993%
Annual Report Gross Expense Ratio0.031.022%
Fund Existence14 years26 years-
Gain YTD-5.166-4.526114%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets24.9B1.47B1,700%
Annual Yield % from dividends1.100.95116%
Returns for 1 year4.632.73169%
Returns for 3 years29.1726.01112%
Returns for 5 years58.1943.91133%
Returns for 10 years63.2512.99487%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHAT10.640.61
+6.08%
Phathom Pharmaceuticals
UPC3.980.09
+2.31%
Universe Pharmaceuticals Inc
BNL16.12-0.19
-1.16%
Broadstone Net Lease
RTO23.39-0.49
-2.05%
Rentokil Initial plc
SCWO0.36-0.05
-11.65%
374Water